Indeed, it has been demonstrated that activated H-RAS, through a kinases cascade involving RAF and extracellular signal-regulated kinase (ERK), promotes NRF2 nuclear translocation and an increase in HO-1, which results in protection of renal cancer cells from apoptosis [107]. Here, NFE2L2 is linked to renal carcinoma.